(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) rose by a staggering 15.36% in 5 sessions from $3.84 at 15.36, to $4.43 at 15:39 EST on Friday, following the last session’s downward trend. NASDAQ is rising 1.13% to $13,248.91, following the last session’s upward trend.

TherapeuticsMD’s last close was $4.15, 64.5% below its 52-week high of $11.69.

About TherapeuticsMD

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Earnings Per Share

As for profitability, TherapeuticsMD has a trailing twelve months EPS of $1.95.

PE Ratio

TherapeuticsMD has a trailing twelve months price to earnings ratio of 2.27. Meaning, the purchaser of the share is investing $2.27 for every dollar of annual earnings.

More news about TherapeuticsMD (TXMD).